Cleared Traditional

K970914 - CHASE AORTIC PERFUSION CANNULA

K970914 is an FDA 510(k) clearance for CHASE AORTIC PERFUSION CANNULA, manufactured by Chase Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DWF cleared through the Traditional 510(k) pathway after a 62-day FDA review.

K970914 · Chase Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1997
Decision
62d
Days
Class 2
Risk

K970914 is an FDA 510(k) clearance for the CHASE AORTIC PERFUSION CANNULA. Classified as Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (product code DWF), Class II - Special Controls.

Submitted by Chase Medical, Inc. (Richardson, US). The FDA issued a Cleared decision on May 13, 1997 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Chase Medical, Inc. devices

FDA 510(k) Submission Details - K970914

510(k) Number K970914 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 12, 1997
Decision Date May 13, 1997
Days to Decision 62 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 125d · This submission: 62d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DWF Device Classification - Class 2, Special Controls

Product Code DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass

All 335
Devices cleared under the same product code (DWF) and FDA review panel - the closest regulatory comparables to K970914.
SARNS VENOUS RETURN CATHETERS WITH DURAFLO TREATMENT
K964374 · 3M Healthcare · Jun 1997
HEARTPORT ENDOARTERIAL RETURN CANNULA
K971291 · Heartport, Inc. · Jun 1997
CHASE LEFT VENT SAFETY VALVE
K964391 · Chase Medical, Inc. · May 1997
CHASE CORONARY OSTIAL PERFUSION CANNULA
K971041 · Chase Medical, Inc. · May 1997
CHASE RETROGRADE CARDIOPLEGIA CANNULA
K964393 · Chase Medical, Inc. · Apr 1997
CHASE AORTIC ARCH CANNULA
K964193 · Chase Medical, Inc. · Apr 1997